Literature DB >> 3876294

The immunosuppressive potency of various steroids on peripheral blood lymphocytes, T cells, NK and K cells.

E Langhoff, J Ladefoged, E Dickmeiss.   

Abstract

The immunosuppressive effect of natural and synthetic steroids was tested in vitro on phytohemagglutinin (PHA) stimulated T lymphocytes and peripheral blood lymphocytes (PBL), as well as on NK and K cell activity. Three groups of steroids, significantly different in their immunosuppressive activity, were identified. Fluorohydrocortisone, and methylprednisolone were highly potent in suppressing PHA stimulation of T lymphocytes and PBL. Hydrocortisone was of intermediate potency, whereas cortisone, dihydrocortisol, and tetrahydrocortisol were of low potency. T lymphocytes were more sensitive to the suppressive effect of fluorohydrocortisone and methylprednisolone than were PBL cultures. NK and K cell activity was suppressed only by the high potency synthetic steroids and even then the suppression of K cell activity was not significant except at high in vitro steroid concentrations. The present findings support the conception that different lymphocyte subpopulations have different susceptibility to the effect of highly potent steroids. Thus, lymphocyte heterogeneity must be taken into account when the immunosuppressive potencies of different glucocorticoids are studied. Furthermore, the findings in different lymphocyte populations ranked the relative in vitro immunosuppressive potency of glucocorticoids different from the relative anti-inflammatory potencies reported in the literature.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876294     DOI: 10.1016/0192-0561(85)90067-0

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  6 in total

1.  Exercise stress alters murine lymphocyte subset distribution in spleen, lymph nodes and thymus.

Authors:  L Hoffman-Goetz; R Thorne; J A Simpson; Y Arumugam
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

2.  Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein.

Authors:  G Mosialos; M Birkenbach; S Ayehunie; F Matsumura; G S Pinkus; E Kieff; E Langhoff
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

3.  In vitro immunosuppressive potency of deflazacort, a new bone-sparing corticosteroid on T lymphocytes, NK and K cells.

Authors:  E Langhoff; K Olgaard
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

4.  Is Timing of Steroid Exposure Prior to Immune Checkpoint Inhibitor Initiation Associated with Treatment Outcomes in Melanoma? A Population-Based Study.

Authors:  Nikita Nikita; Joshua Banks; Scott W Keith; Andrew Song; Jennifer M Johnson; Melissa Wilson; Swapnil Sharma; Grace Lu-Yao
Journal:  Cancers (Basel)       Date:  2022-03-02       Impact factor: 6.639

5.  Methylprednisolone Pulses in Hospitalized COVID-19 Patients Without Respiratory Failure: A Randomized Controlled Trial.

Authors:  Iñigo Les; Jose Loureiro-Amigo; Ferran Capdevila; Isabel Oriol; Iñaki Elejalde; Judit Aranda-Lobo; Joao Modesto; Elena Güell-Farré; Ruth García; Anna Murgadella-Sancho; Javier Anniccherico; Miguel Martín-Fernández; José Javier Lorza; Joan-Pol Monteys-Montblanch; Julián Librero; Sara Pintado-Lalueza; Marina Delgado; Berta Gracia-García; Julio Sánchez-Álvarez; Melani Pestaña-Fernández; Patricia Fanlo; Gisela Funalleras-Puig; Maite Sarobe; Eduardo Mediavilla; Carlos Ibero
Journal:  Front Med (Lausanne)       Date:  2022-02-28

6.  Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong.

Authors:  Loretta Yin-Chun Yam; Arthur Chun-Wing Lau; Florence Yuk-Lin Lai; Edwina Shung; Jane Chan; Vivian Wong
Journal:  J Infect       Date:  2006-03-15       Impact factor: 6.072

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.